32,296 Shares of Humana Inc. $HUM Bought by Chapin Davis Inc.

Chapin Davis Inc. bought a new stake in Humana Inc. (NYSE:HUM) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 32,296 shares of the insurance provider’s stock, valued at approximately $12,323,000. Humana accounts for about 2.5% of Chapin Davis Inc.’s investment portfolio, making the stock its 12th biggest holding.

Several other hedge funds have also bought and sold shares of HUM. BlackRock Inc. acquired a new position in Humana during the second quarter worth approximately $4,138,160,000. Pzena Investment Management LLC increased its holdings in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the last quarter. Legal & General Group Plc bought a new stake in Humana in the 2nd quarter valued at $329,760,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Humana during the 2nd quarter valued at $314,922,000. Finally, Wellington Management Group LLP boosted its position in Humana by 7.3% during the second quarter. Wellington Management Group LLP now owns 765,355 shares of the insurance provider’s stock worth $304,014,000 after purchasing an additional 52,004 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on HUM. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price for the company in a research note on Thursday, July 30th. Zacks Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. HSBC downgraded shares of Humana to a “hold” rating in a research report on Thursday, July 30th. Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Finally, UBS Group initiated coverage on Humana in a research note on Thursday, July 30th. They set a “buy” rating on the stock. Sixteen equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Moderate Buy” and a consensus price target of $431.48.

Humana Stock Down 2.2%

NYSE HUM opened at $387.68 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $46.55 billion, a price-to-earnings ratio of 36.68, a PEG ratio of 2.45 and a beta of 0.74. The company has a 50 day moving average of $387.26 and a 200-day moving average of $332.87. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the business posted $6.27 earnings per share. The firm’s quarterly revenue was up 26.2% compared to the same quarter last year. On average, equities research analysts expect that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a $0.8850 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s dividend payout ratio (DPR) is presently 33.49%.

Humana News Summary

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Improved 2027 Medicare Advantage Star Ratings support the bullish case. Humana reportedly received a boost in its 2027 ratings, potentially improving bonus economics and Medicare Advantage margins. The news prompted a sharp post-market reaction as investors reassessed the company’s earnings outlook. Humana surges post-market on boost in 2027 Medicare Advantage star ratings
• Positive Sentiment: Analyst upgrade adds support. Cantor Fitzgerald raised Humana to “Overweight” from “Neutral” and lifted its price target to $460 from $300, citing improving prospects for the insurer. Humana stock rating raised to Overweight at Cantor Fitzgerald
• Neutral Sentiment: Upcoming earnings remain a major catalyst. Humana is scheduled to report its third-quarter 2026 results, giving investors an opportunity to assess medical-cost trends and whether improved Star Ratings are translating into stronger financial performance. Humana sets date for third-quarter 2026 interim report
• Neutral Sentiment: A report highlighting Humana’s roughly $13 billion economic impact in Louisville reinforces the company’s local significance but is unlikely to materially affect near-term valuation. Report highlights Humana’s $13B impact in Louisville
• Negative Sentiment: Volatility and elevated expectations remain risks. HUM had recently rallied on expectations for better Medicare margins and ratings, so the earlier decline likely reflected profit-taking and uncertainty ahead of CMS’s announcement. The stock also trades above several published analyst targets, increasing sensitivity to any disappointment in the ratings or upcoming earnings.

About Humana

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.